The agency’s decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.
Related Posts
2025 could end up being the year of the spinoff as break-ups like Honeywell abound
Lennar’s spinoff of Millrose Properties last week kicks off a spinoff calendar that many expect will ramp up this year.
Shedeur Sanders selected by Cleveland Browns after falling to fifth round of NFL draft
The Colorado star quarterback was the 144th pick in the fifth round of the NFL Draft on Saturday, a stunning slide for what was considered […]
CoreWeave aims to raise up to $2.7 billion in IPO
In its updated IPO prospectus on Thursday, CoreWeave said it plans to sell shares at $47 to $55 each, raising a total of up to […]